Patents by Inventor Christian Isak Joergensen

Christian Isak Joergensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230295591
    Abstract: Disclosed is variants of a cellulase having improved stability in the presence of a protease, and the use of such variants in laundry.
    Type: Application
    Filed: January 11, 2023
    Publication date: September 21, 2023
    Applicant: Novozymes A/S
    Inventors: Svend Gunnar Kaasgaard, Frank Winther Rasmussen, Roland Alexander Pache, Lars Anderson, Mette Louise Dissing Overgaard, Thomas Agersten Poulsen, Dorte Marie Koefoed Klitgaard, Christian Isak Joergensen, Lars Giger
  • Publication number: 20230143128
    Abstract: Disclosed are carbohydrate binding module variants, as well as variants of a glycoside hydrolase comprising the carbohydrate binding module variants. The variants having glycoside hydrolase activity comprising the carbohydrate binding module variants have improved stability in the presence of a protease, and are useful in detergent applications, such as laundry or dish wash.
    Type: Application
    Filed: April 7, 2021
    Publication date: May 11, 2023
    Applicant: Novozymes A/S
    Inventors: Kenneth Jensen, Lars Anderson, Svend Gunnar Kaasgaard, Jonatan Ulrik Fangel, Frank Winther Rasmussen, Pengfei Tian, Christian Isak Joergensen
  • Patent number: 11566239
    Abstract: Disclosed is variants of a cellulase having improved stability in the presence of a protease, and the use of such variants in laundry.
    Type: Grant
    Filed: April 12, 2019
    Date of Patent: January 31, 2023
    Assignee: Novozymes A/S
    Inventors: Svend Gunnar Kaasgaard, Frank Winther Rasmussen, Roland Alexander Pache, Lars Anderson, Mette Louise Dissing Overgaard, Thomas Agersten Poulsen, Dorte Marie Koefoed Klitgaard, Christian Isak Joergensen, Lars Giger
  • Publication number: 20210363510
    Abstract: Disclosed is variants of a cellulase having improved stability in the presence of a protease, and the use of such variants in laundry.
    Type: Application
    Filed: April 12, 2019
    Publication date: November 25, 2021
    Applicant: Novozymes A/S
    Inventors: Svend Gunnar Kaasgaard, Frank Winther Rasmussen, Roland Alexander Pache, Lars Anderson, Mette Louise Dissing Overgaard, Thomas Agersten Poulsen, Dorte Marie Koefoed Klitgaard, Christian Isak Joergensen, Lars Giger
  • Patent number: 10954499
    Abstract: The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: February 21, 2019
    Date of Patent: March 23, 2021
    Assignee: Novozymes A/S
    Inventors: Hanne Risbjerg Soerensen, Christel Thea Joergensen, Lars Hylling Christensen, Christian Isak Joergensen, Carsten Hoerslev Hansen, Lene Venke Kofod
  • Publication number: 20190177711
    Abstract: The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.
    Type: Application
    Filed: February 21, 2019
    Publication date: June 13, 2019
    Applicant: Novozymes A/S
    Inventors: Hanne Risbjerg Soerensen, Christel Thea Joergensen, Lars Hylling Christensen, Christian Isak Joergensen, Carsten Hoerslev Hansen, Lene Venke Kofod
  • Patent number: 10233434
    Abstract: The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: October 5, 2017
    Date of Patent: March 19, 2019
    Assignee: Novozymes A/S
    Inventors: Hanne Risbjerg Soerensen, Christel Thea Joergensen, Lars Hylling Christensen, Christian Isak Joergensen, Carsten Hoerslev Hansen, Lene Venke Kofod
  • Publication number: 20180044650
    Abstract: The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.
    Type: Application
    Filed: October 5, 2017
    Publication date: February 15, 2018
    Applicant: Novozymes A/S
    Inventors: Hanne Risbjerg Soerensen, Christel Thea Joergensen, Lars Hylling Christensen, Christian Isak Joergensen, Carsten Hoerslev Hansen, Lene Venke Kofod
  • Patent number: 9822349
    Abstract: The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated nucleic acid sequences encoding the polypeptides, such that the nucleic acid is operably linked to a heteroloqous control sequence for expression. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides set forth in SEQ ID NO:2 and fragments of SEQ ID NO:2.
    Type: Grant
    Filed: August 9, 2016
    Date of Patent: November 21, 2017
    Assignee: Novozymes A/S
    Inventors: Hanne Risbjerg Soerensen, Christel Thea Joergensen, Lars Hylling Christensen, Christian Isak Joergensen, Carsten Hoerslev Hansen, Lene Venke Kofod
  • Publication number: 20170015984
    Abstract: The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.
    Type: Application
    Filed: August 9, 2016
    Publication date: January 19, 2017
    Inventors: Hanne Risbjerg Soerensen, Christel Thea Joergensen, Lars Hylling Christensen, Christian Isak Joergensen, Carsten Hoerslev Hansen, Lene Venke Kofod
  • Patent number: 9428741
    Abstract: The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated nucleic acid sequences encoding the polypeptides, such that the nucleic acid is operably linked to a heterologous control sequence for expression. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides set forth in SEQ ID NO: 2 and fragments of SEQ ID NO: 2.
    Type: Grant
    Filed: April 7, 2015
    Date of Patent: August 30, 2016
    Assignee: Novozymes A/S
    Inventors: Hanne Risbjerg Soerensen, Christel Thea Joergensen, Lars Hylling Christensen, Christian Isak Joergensen, Carsten Hoerslev Hansen, Lene Venke Kofod
  • Publication number: 20150210990
    Abstract: The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.
    Type: Application
    Filed: April 7, 2015
    Publication date: July 30, 2015
    Inventors: Hanne Risbjerg Soerensen, Christel Thea Joergensen, Lars Hylling Christensen, Christian Isak Joergensen, Carsten Hoerslev Hansen, Lene Venke Kofod
  • Patent number: 8383391
    Abstract: This disclosure relates to mutant cells with deleted or disrupted genes encoding protease(s).
    Type: Grant
    Filed: September 30, 2008
    Date of Patent: February 26, 2013
    Assignee: Novozymes A/S
    Inventors: Hiroaki Udagawa, Christian Isak Jørgensen
  • Patent number: 8288510
    Abstract: The invention provides for isolated peptides having phospholipase inhibitory activity, polypeptides comprising phospholipase inhibitory activity and lipases capable of being inhibited by the isolated peptides and/or polypeptides comprising phospholipase inhibitory activity. The invention also relates to nucleic acid constructs, recombinant expression vectors, and recombinant host cells comprising the polynucleotides as well as methods for producing and using the peptides and the polypeptides having lipase inhibitory activity.
    Type: Grant
    Filed: April 30, 2009
    Date of Patent: October 16, 2012
    Assignee: Novozymes A/S
    Inventors: Leonardo de Naria, Ming Li, Christian Isak Joergensen, Kim Borch, Tom Anton Busk Nielsen, Jesper Vind
  • Patent number: 7993890
    Abstract: The present invention relates to a process for enzymatic hydrolysis of arabinoxylan, and an enzyme composition suitable for use in such a process.
    Type: Grant
    Filed: April 25, 2006
    Date of Patent: August 9, 2011
    Assignee: Novozymes A/S
    Inventors: Hanne Risbjerg Soerensen, Sven Pedersen, Anders Viksoe-Nielsen, Christel Thea Joergensen, Lars Hylling Christensen, Christian Isak Joergensen, Carsten Hoerslev Hansen, Lene Venke Kofod
  • Publication number: 20100304433
    Abstract: The present invention relates to isolated polypeptides having protease activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Application
    Filed: September 30, 2008
    Publication date: December 2, 2010
    Applicant: Novozymes A/S
    Inventors: Hiroaki Udagawa, Christian Isak Jørgensen
  • Publication number: 20090275083
    Abstract: The invention provides for isolated peptides having phospholipase inhibitory activity, polypeptides comprising phospholipase inhibitory activity and lipases capable of being inhibited by the isolated peptides and/or polypeptides comprising phospholipase inhibitory activity. The invention also relates to nucleic acid constructs, recombinant expression vectors, and recombinant host cells comprising the polynucleotides as well as methods for producing and using the peptides and the polypeptides having lipase inhibitory activity.
    Type: Application
    Filed: April 30, 2009
    Publication date: November 5, 2009
    Applicant: Novozymes A/S
    Inventors: Leonardo De Maria, Ming Li, Christian Isak Joergensen, Kim Borch, Tom Anton Busk Nielsen, Jesper Vind
  • Publication number: 20090136476
    Abstract: The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.
    Type: Application
    Filed: April 25, 2006
    Publication date: May 28, 2009
    Applicant: Novozymes A/S
    Inventors: Hanne Risbjerg Soerensen, Christel Thea Joergensen, Lars Hylling Christensen, Christian Isak Joergensen, Carsten Hoerslev Hansen, Lene Venke Kofod
  • Publication number: 20080274527
    Abstract: The present invention relates to a process for enzymatic hydrolysis of arabinoxylan, and an enzyme composition suitable for use in such a process.
    Type: Application
    Filed: April 25, 2006
    Publication date: November 6, 2008
    Applicant: Novozymes A/S
    Inventors: Hanne Risbjerg Soerensen, Sven Pedersen, Anders Viksoe-Nielsen, Christel Thea Joergensen, Lars Hylling Christensen, Christian Isak Joergensen, Carsten Hoerslev Hansen, Lene Venke Kofod